Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 03, 2015 6:24 PM ET

Healthcare Equipment and Supplies

Company Overview of Keystone Heart, Ltd.

Company Overview

Keystone Heart, Ltd., a medical device company, focuses on the development and commercialization of procedural tools and accessories for use during transcatheter aortic valve implantation (TAVI) and other complex percutaneous structural heart procedures. It designs and develops an embolic deflection device to reduce the chance of stroke and embolic events during TAVI and other structural heart procedures. The company also designs and develops cerebral protection devices to reduce the incidence of brain injury (stroke and silent stroke) during complex catheter-based interventions. Keystone Heart, Ltd. was formerly known as SMT R&D Ltd. and changed its name to Keystone Heart, Ltd. in April 201...

20 Galgaley Haplada Street

Herzliya Pituach Industrial Park

Herzliya,  46722

Israel

Founded in 2004

Phone:

972 9 950 8089

Fax:

972 9 950 8103

Key Executives for Keystone Heart, Ltd.

Chief Executive Officer and President
Chief Financial Officer and Vice President
Chief Medical Officer and Vice President
Chief Technology officer
Compensation as of Fiscal Year 2014.

Keystone Heart, Ltd. Key Developments

Keystone Heart, Ltd.'s TriGuard(TM) Cerebral Protection Device Receives CE Marking

Keystone Heart, Ltd. announced that its TriGuard(TM) Cerebral Protection Device has received CE Marking, enabling the company to commercially market the TriGuard in Europe and other territories. The CE marking recognizes the conformity of the TriGuard device with the relevant directive of the European Community. The CE marked TriGuard is the device designed to cover all three aortic cerebral branches to minimize the risk of cerebral damage during Transcatheter Aortic Valve Replacement (TAVR) and other cardiovascular procedures. It is the only system designed for placement via one of two femoral artery access ports. The TriGuard(TM) accommodates most anatomical variations of the aortic arch and uses a Nitinol(R) frame and mesh - flexible and atraumatic, yet robust and sturdy.

Similar Private Companies By Industry

Company Name Region
Eyoca Medical Middle East/Africa
MinInvasive Ltd. Middle East/Africa
Degania Silicone Ltd. Middle East/Africa
ProTechT Middle East/Africa
FlowMedic, Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Keystone Heart, Ltd., please visit www.keystoneheart.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.